Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Sepsis 1Neoplasms 1

Interventions

Anti-Bacterial Agents 2ziprasidone 1telavancin 1soybean oil, phospholipid emulsion 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Trimethoprim, Sulfamethoxazole Drug Combination 1Tranexamic Acid 1Tobramycin 1Spironolactone 1Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization 1Sevelamer 1Saline Solution 1Rocuronium 1Povidone-Iodine 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Multiplex Polymerase Chain Reaction 1Molindone 1Methylprednisolone 1Methods 1Meropenem 1Massage 1Lurasidone Hydrochloride 1Levofloxacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Sepsis × Hydrochloric Acid × Clear all
NCT05376566 2026-03-24

Hydrochloric Acid Lock Therapy for Central Line-associated Bloodstream Infections

Rigshospitalet, Denmark

Phase NA Completed
212 enrolled

Neoplasms, Sepsis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡